Antoine Klauser1,2, Sebastien Courvoisier1,2, Michel Kocher1,2, and François Lazeyras1,2
1Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland, 2CIBM Center for Biomedical Imaging, Geneva, Switzerland
Synopsis
A
fast 1H 3D Adiabatic Spin-Echo (ADISE) MRSI sequence was implemented
to measure metabolite distributions over the whole brain with 5mm
isotropic resolution. MRSI data were measured on volunteers and
compared with FID-MRSI sequence. ADISE-MRSI and FID-MRSI
acquisitions were accelerated with compressed-sensing and
reconstructed with a Low-Rank TGV-constrained model.
Introduction:
Free
induction decay -MRSI (FID-MRSI) is a fast sequence that enables
measurement
of metabolic profiles across the whole brain at ultra-short echo-time
(TE) and in high spatial resolution in 2D1,2,3
or 3D9,10,11.
The simple excite-acquire scheme of the sequence allows to reduce the
repetition time (TR), and hence
the acquisition
time significantly by using a low flip angle, enabling
whole-brain high-resolution acquisition in a reasonable time by
combining with the other acceleration methods.4,5,9 However,
the FID-MRSI is a sequence scheme that might suffer from B0
field in-homogeneity due to its gradient-echo architecture.
We
implemented the Fast ADISE MRSI sequence including a signal
refocusing pulse that would circumvent the T2* susceptibility of
FID-MRSI but with the same low flip-angle, same TR, with the shortest
possible
TE, to match FID-MRSI acquisition time. Also, considering the large
excitation slab of a 3D-MRSI sequence, adiabatic full passage (AFP)
pulses were chosen to minimize the chemical shift artefact in the
slab-through direction.
Additionaly,
the
3D Cartesian encoding was randomly undersampled to enable
compressed-sensing acceleration9
with a low-rank total generalized variation (TGV)-constrained
reconstruction.
High-resolution
3D metabolite maps obtained by both acquisition sequences are
compared using their respective Cramer-Rao-Lower-Bound (CRLB) values
and spectral quality parameters (SNR,FWHM).Methods
A
volume selective 3D ADISE-MRSI sequence including WET water
suppression was developed and implemented on a 3T Prisma-Fit system
(Siemens Healthineers). The excitation pulse of 0.9 ms was designed
with a Shinnar-Le Roux algorithm and adjusted to excite 150% of the
slab thickness. The excitation was followed by two adiabatic
full-passage hyperbolic-secant pulses of 5ms with slab selective
gradients and crushers set to refocus 100% of the slab thickness.
This spin-echo sequence was made Fast
with the shortest possible TE (20ms) and TR (360 ms) (Fig.1 A) and a
low excitation flip-angle (35deg). The signal was recorded with 1024
points over a 4 kHz bandwidth.
The 3D FID-MRSI sequence used for
the comparison
(Fig.1
B) contains the same excitation pulse and has the same spectral
resolution bandwidth and TR of 360 ms. The TE (or acquisition-delay
in this case) was 0.6ms.
The
excited slab size was (A/P-R/L-H/F) 210x160x100mm. The 3D encoding
volume was set slightly larger to 210x60x110mm to prevent aliasing
and the encoding matrix was 42x32x22 resulting in a 125 μl
voxel nominal volume (5mm isotropic).
For
both ADISE and FID-MRSI, 3D Cartesian encoding was performed
following a random undersampling pattern with a variable density8,9
given
by
an acceleration factor of 3.5 which
allowed
an acquisition time of 20min (Fig.1 C).
Three
healthy volunteers were scanned with 64-channel receiver head coil. A
3D-T1-weighted MPRAGE
sequence
was acquired for anatomical reference. The 3D ADISE-MRSI and FID-MRSI
were acquired in a row with the same FOV and excitations slab
followed by a
fast water reference scan. The
water reference measurement was acquired to determine the coil
sensitivity and the B0 fieldmap with the same FID-MRSI sequence but
with a TR of 31 ms, 48 FID points, 5-degree flip angle and a full
elliptical k-space coverage.
The
acquired undersampled 3D MRSI data were cleaned from skull lipids by
lipid-metabolite spectral orthogonality
8,9
and reconstructed with low-rank TGV regularized model7,8,9.
The reconstructed MRSI dataset was then
quantified using LCModel12
to
results in maps of
NAA+NAAG (N-acetylaspartate and N-acetyl aspartylglutamate), Cre+PCr
(total creatine), Cho (choline-containing compounds), Ins
(myo-inositol) and Glu+Gln (glutamate and glutamine).Results
In
Fig.2, metabolite
volumes resulting from the 3D Fast ADISE-MRSI sequence are exhibited
with a quality reflected by the anatomical contrast highlighted in
all metabolite distributions. Typical contrast for Cre+PCre and Cho
metabolite are present but the metabolite signal loss is still
visible
in region of strong B0 inhomogeneity e.g.
in the lowest frontal lobes.
In
Fig.3, the comparison between 3D Fast ADISE-MRSI
versus 3D FID-MRSI illustrates the close similarity of the results.
Due to longer TE timing, signal of ADISE-MRSI is slightly lower as
shown by the sample spectra in Fig.3 and SNR maps presented in Fig.4.
The fitting error estimated by CRLB values tend to be slightly higher
for ADISE-MRSI than FID-MRSI as depicted by the histograms in Fig.4.
Use of ADISE-MRSI doesn’t improve much for signal loss due to B0
inhomogeneities. Although metabolite signal is refocussed by the spin
echo sequence, the strong T2* relaxation consecutive to the B0
inhomogeneity results in a significant increase of the linewidth, and
reduction of detectable metabolite signal. This phenomenon occurs
identically in both sequences as illustrated by FWHM maps in Fig.4.Discussion
Original
results of whole brain 3D Fast ADISE-MRSI were presented with a
demonstration of the good quality of the results. Although metabolite
signal is refocussed by the two AFP pulses, there is still a strong
signal loss in B0 inhomogeneity regions probably consecutive to T2*
relaxation during FID. The
overall
spectral quality and quantification error are better using a FID-MRSI
sequence, the results presented here demonstrate the feasibility of
performing a spin-echo MRSI
sequence in a reduced scan time over the whole brain. This paves the
way to implementation of the Fast ADISE-MRSI sequence with any TE to
highlight specific metabolite or the techniques
of spectral editing techniques requiring spin-echo.Acknowledgements
No acknowledgement found.References
[1] Henning, A., Fuchs, A., Murdoch, J.B. and Boesiger, P. (2009).
NMR Biomed 22, 683-696.
[2] Nassirpour, S., Chang, P.,
Henning, A. (2017). NeuroImage, 168, 211–221.
[3] Hangel, G.,
Strasser, B., Považan, M., Heckova, E., Hingerl, L., Boubela, R., …
Bogner, W. (2018). NeuroImage, 168(October), 199–210.
[4]
Strasser, B., Považan, M., Hangel, G., Hingerl, L., Chmelik, M.,
Gruber, S., … Bogner, W. (2017). Magnetic Resonance in Medicine,
78(2), 429–440.
[5] Nassirpour, S., Chang, P., Avdievitch,
N., & Henning, A. (2018). Magnetic Resonance in Medicine, 80(6),
2311–2325.
[7] Kasten, J., Lazeyras, F., & Van De Ville,
D. (2013), IEEE TMI, 32(10), 1853–1863.
[8] Klauser, A.,
Courvoisier, S., Kasten, J., Kocher, M., Guerquin-Kern, M., Van De
Ville, D., & Lazeyras, F. (2019). Magnetic Resonance in Medicine,
81(5), 2841–2857.
[9] Klauser, A., Klauser, P., Grouiller, F.,
Courvoisier, S., & Lazeyras, F. (2020). BioRxiv,
2020.05.18.101618.
[10] Hingerl, L., Strasser, B., Moser, P.,
Hangel, G., Motyka, S., Heckova, E., … Bogner, W. (2019).
Investigative Radiology, 55(4), 239–248.
[11] Moser, P.,
Eckstein, K., Hingerl, L., Weber, M., Motyka, S., Strasser, B., …
Bogner, W. (2019). Magnetic Resonance in Medicine, 83(6),
1920–1929.
[12] Provencher, S.W. (1993). Magn Reson Med 30,
672-679.